Haloperidol versus placebo for schizophrenia
28 results
1 - 28
Haloperidol versus placebo for schizophrenia
Haloperidol versus placebo for schizophrenia - Schizophrenia
- Depot haloperidol decanoate for schizophrenia
- Haloperidol discontinuation for people with schizophrenia
- Risperidone versus placebo for schizophrenia
- Antipsychotic medication for childhood‐onset schizophrenia
- Sulpiride versus placebo for schizophrenia
- Atypical antipsychotics for people with both schizophrenia and depression
- Bromperidol decanoate (depot) for schizophrenia: Cochrane systematic review
- Sertindole for schizophrenia
- Aripiprazole versus placebo for schizophrenia: Cochrane systematic review
- Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia
- Bifeprunox versus placebo for schizophrenia
- Perphenazine for schizophrenia
- Carbamazepine for schizophrenia
- Non‐antipsychotic catecholaminergic drugs for antipsychotic‐induced tardive dyskinesia
- Benzodiazepines for psychosis‐induced aggression or agitation
- Zuclopenthixol dihydrochloride for schizophrenia
- Zuclopenthixol dihydrochloride for schizophrenia
- Thioridazine for schizophrenia
- Risperidone for psychosis‐induced aggression or agitation (rapid tranquillisation)
- Clotiapine for acute psychotic illnesses